Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Gilead Sciences, Inc.    GILD   US3755581036

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/17/2013 05/20/2013 05/21/2013 05/22/2013 05/23/2013 Date
56.3(c) 55.74(c) 56.47(c) 55.93(c) 55.48(c) Last
13 909 763 9 499 365 10 089 914 12 767 258 10 721 645 Volume
+2.44% -0.99% +1.31% -0.96% -0.80% Change
More quotes
Company
Gilead Sciences specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (96.9%): for the treatment of HIV (86.6% of net sales), fungal infections (3.7%) and other (9.7%; primarily cytomegalovirus... 
Read more
Sector
Biotechnology
Calendar
07/23Earnings Release
Surperformance© rating of Gilead Sciences, Inc.
Trading Rating : Investor Rating :
More about the company
Chart GILEAD SCIENCES, INC.
Duration : Period :
Gilead Sciences, Inc. Technical Analysis Chart | GILD | US3755581036 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 10 610 M
EBIT 2013 4 641 M
Net income 2013 2 963 M
Debt 2013 3 763 M
Yield 2013 -
Sales 2014 12 921 M
EBIT 2014 6 681 M
Net income 2014 4 340 M
Debt 2014 224 M
Yield 2014 -
PER 2013 31,21
PER 2014 20,70
EV / Sales 2013 8,40x
EV / Sales 2014 6,62x
Capitalization 85 313 M
More Financials
Latest news on GILEAD SCIENCES, INC.
1d agoDJRoyalty Pharma Lowers Acceptance Threshold For Elan Offer
2d agoDJU.S. HOT STOCK FUTURES: Hot stocks to watch
3d ago GILEAD SCIENCES, INC.: European Medicines Agency Validates Gilead’s Marketing A..
3d agoDJGILEAD SCIENCES, INC.: Gilead Hepatitis C Drug Gets Accelerated Review
3d agoDJGILEAD SCIENCES, INC.: Gilead Hepatitis C Drug Sofosbuvir Granted Accelerated R..
3d ago GILEAD SCIENCES, INC.: European Medicines Agency Validates Gilead's Marketing A..
4d agoDJRoyalty Pharma Raises Takeover Bid for Elan
7d ago GILEAD SCIENCES, INC.: Gilead Sciences to Present at the 2013 UBS Global Health..
05/15 GILEAD SCIENCES, INC.: Gilead Announces Response Data from Phase 2 Study of Ide..
05/14 GILEAD SCIENCES, INC.: Gilead Sciences to Present at the Bank of America Merril..
05/10 Drugmakers face more scrutiny of discordant U.S. prices
05/06DJAbbVie's Investigational Hepatitis C Virus Regimen Gets Breakthrough-Therapy ..
More news
Forum GILEAD SCIENCES, INC.
Be the first to post a message on GILEAD SCIENCES, INC.
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Gilead Sciences, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Gilead Sciences, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.